Atorvastatin in Management of Newly Diagnosed ITP

Clinical trial NCT03692754 · UNKNOWN

Trial details

NCT number: NCT03692754
Sponsor: Shandong University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia Purpura, Thrombocytopenic

Start date: 2021-11-01
Primary completion: 2021-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.